The analysis of tumor subtypes revealed a distribution of alterations in the EZH2, EED, and SUZ12 genes (amplifications, deep deletions, mutations, fusions, and multiple alterations) in the 20 most common tumor subtypes (at least 50 samples per each subtype). This evidence concerns the gene EZH2 and neoplasm.